459 related articles for article (PubMed ID: 27634541)
1. Pangenome and immuno-proteomics analysis of Acinetobacter baumannii strains revealed the core peptide vaccine targets.
Hassan A; Naz A; Obaid A; Paracha RZ; Naz K; Awan FM; Muhmmad SA; Janjua HA; Ahmad J; Ali A
BMC Genomics; 2016 Sep; 17(1):732. PubMed ID: 27634541
[TBL] [Abstract][Full Text] [Related]
2. A novel approach of virulome based reverse vaccinology for exploring and validating peptide-based vaccine candidates against the most troublesome nosocomial pathogen: Acinetobacter baumannii.
Ahmad S; Azam SS
J Mol Graph Model; 2018 Aug; 83():1-11. PubMed ID: 29753164
[TBL] [Abstract][Full Text] [Related]
3. Chimeric vaccine designs against Acinetobacter baumannii using pan genome and reverse vaccinology approaches.
Shahid F; Zaheer T; Ashraf ST; Shehroz M; Anwer F; Naz A; Ali A
Sci Rep; 2021 Jun; 11(1):13213. PubMed ID: 34168196
[TBL] [Abstract][Full Text] [Related]
4. Antibiotic Resistance Determinant-Focused Acinetobacter baumannii Vaccine Designed Using Reverse Vaccinology.
Ni Z; Chen Y; Ong E; He Y
Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28230771
[TBL] [Abstract][Full Text] [Related]
5. Combating tigecycline resistant Acinetobacter baumannii: A leap forward towards multi-epitope based vaccine discovery.
Ahmad S; Ranaghan KE; Azam SS
Eur J Pharm Sci; 2019 Apr; 132():1-17. PubMed ID: 30797936
[TBL] [Abstract][Full Text] [Related]
6. Vaccinomics to Design a Multi-Epitopes Vaccine for
Ud-Din M; Albutti A; Ullah A; Ismail S; Ahmad S; Naz A; Khurram M; Haq MU; Afsheen Z; Bakri YE; Salman M; Shaker B; Tahir Ul Qamar M
Int J Environ Res Public Health; 2022 May; 19(9):. PubMed ID: 35564967
[TBL] [Abstract][Full Text] [Related]
7. Subtractive proteomics to identify novel drug targets and reverse vaccinology for the development of chimeric vaccine against Acinetobacter baumannii.
Solanki V; Tiwari V
Sci Rep; 2018 Jun; 8(1):9044. PubMed ID: 29899345
[TBL] [Abstract][Full Text] [Related]
8. Immuno-informatics driven proteome-wide investigation revealed novel peptide-based vaccine targets against emerging multiple drug resistant Providencia stuartii.
Asad Y; Ahmad S; Rungrotmongkol T; Ranaghan KE; Azam SS
J Mol Graph Model; 2018 Mar; 80():238-250. PubMed ID: 29414043
[TBL] [Abstract][Full Text] [Related]
9. Delineating the Plausible Molecular Vaccine Candidates and Drug Targets of Multidrug-Resistant
Mujawar S; Mishra R; Pawar S; Gatherer D; Lahiri C
Front Cell Infect Microbiol; 2019; 9():203. PubMed ID: 31281799
[TBL] [Abstract][Full Text] [Related]
10. EpitoCore: Mining Conserved Epitope Vaccine Candidates in the Core Proteome of Multiple Bacteria Strains.
Fiuza TS; Lima JPMS; de Souza GA
Front Immunol; 2020; 11():816. PubMed ID: 32431712
[TBL] [Abstract][Full Text] [Related]
11. Physicochemical and structural characterization, epitope mapping and vaccine potential investigation of a new protein containing Tetratrico Peptide Repeats of Acinetobacter baumannii: An in-silico and in-vivo approach.
Abdollahi S; Raoufi Z; Fakoor MH
Mol Immunol; 2021 Dec; 140():22-34. PubMed ID: 34649027
[TBL] [Abstract][Full Text] [Related]
12. Genomic features, whole-genome phylogenetic and comparative genomic analysis of extreme-drug-resistant ventilator-associated-pneumonia Acinetobacter baumannii strain in a Vietnam hospital.
Si-Tuan N; Ngoc HM; Nhat LD; Nguyen C; Pham HQ; Huong NT
Infect Genet Evol; 2020 Jun; 80():104178. PubMed ID: 31917358
[TBL] [Abstract][Full Text] [Related]
13. Designing Multi-Antigen Vaccines Against
McConnell MJ; MartÃn-Galiano AJ
Front Immunol; 2021; 12():666742. PubMed ID: 33936107
[TBL] [Abstract][Full Text] [Related]
14. Identification of potential antigens from non-classically secreted proteins and designing novel multitope peptide vaccine candidate against Brucella melitensis through reverse vaccinology and immunoinformatics approach.
Vishnu US; Sankarasubramanian J; Gunasekaran P; Rajendhran J
Infect Genet Evol; 2017 Nov; 55():151-158. PubMed ID: 28919551
[TBL] [Abstract][Full Text] [Related]
15. Identification of Antigenic Properties of Acinetobacter baumannii Proteins as Novel Putative Vaccine Candidates Using Reverse Vaccinology Approach.
Piri-Gharaghie T; Doosti A; Mirzaei SA
Appl Biochem Biotechnol; 2022 Oct; 194(10):4892-4914. PubMed ID: 35670904
[TBL] [Abstract][Full Text] [Related]
16. Putative novel B-cell vaccine candidates identified by reverse vaccinology and genomics approaches to control Acinetobacter baumannii serotypes.
Beiranvand S; Doosti A; Mirzaei SA
Infect Genet Evol; 2021 Dec; 96():105138. PubMed ID: 34793968
[TBL] [Abstract][Full Text] [Related]
17. Identification of novel vaccine candidates against multidrug-resistant Acinetobacter baumannii.
Moriel DG; Beatson SA; Wurpel DJ; Lipman J; Nimmo GR; Paterson DL; Schembri MA
PLoS One; 2013; 8(10):e77631. PubMed ID: 24116234
[TBL] [Abstract][Full Text] [Related]
18. New putative vaccine candidates against Acinetobacter baumannii using the reverse vaccinology method.
Fereshteh S; Abdoli S; Shahcheraghi F; Ajdary S; Nazari M; Badmasti F
Microb Pathog; 2020 Jun; 143():104114. PubMed ID: 32145321
[TBL] [Abstract][Full Text] [Related]
19. In Silico Design and Evaluation of Acinetobacter baumannii Outer Membrane Protein a Antigenic Peptides As Vaccine Candidate in Immunized Mice.
Mehdinejadiani K; Bandehpour M; Hashemi A; Ranjbar MM; Taheri S; Jalali SA; Mosaffa N
Iran J Allergy Asthma Immunol; 2019 Nov; 18(6):655-663. PubMed ID: 32245309
[TBL] [Abstract][Full Text] [Related]
20. An in silico structural and physicochemical characterization of TonB-dependent copper receptor in A. baumannii.
Abdollahi S; Rasooli I; Mousavi Gargari SL
Microb Pathog; 2018 May; 118():18-31. PubMed ID: 29524546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
